topical ghk-cu results Copper Peptide Before and After: GHK-Cu for Anti-Aging: Does This

Bolanos, J

This study aims to assess the functional outcomes of combining BTX-A infiltration and NMR in treating synkinesis in peripheral FNP patients

Confirmatory secondary endpoints included 20%, 25%, and 30% weight loss, with all analyses performed on an intention-to-treat basis and reported with 95% confidence intervals

Clinical studies show that oral semaglutide (14 mg) resulted in a 5.7% reduction in body weight after one year

Unlike synthetic actives that force a reaction, GHK-Cu works with biological signaling pathways the body already recognizes

Diseases such as Alzheimers, dementia, sarcopenia, arthritis, Parkinsons, osteoporosis, maculopathy, COPD, and cancer increase with advancing age (Franceschi et al 2018)